Volume 8, Issue 3, Pages (March 2011)

Slides:

Advertisements

Similar presentations

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Advertisements

Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in CKD: A Meta-analysis of Patient-Level Data From 3 Randomized.

Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter.

Journal of Cardiac Failure

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Volume 12, Issue 7, Pages (July 2015)

Volume 13, Issue 3, Pages (March 2016)

Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness.

Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT)

Volume 11, Issue 8, Pages (August 2014)

Volume 13, Issue 1, Pages (January 2016)

Volume 7, Issue 10, Pages (October 2010)

Volume 5, Issue 4, Pages (April 2008)

Ragavendra R. Baliga, MD, MBA Heart Failure Clinics

Volume 10, Issue 10, Pages (October 2013)

Volume 15, Issue 4, Pages (April 2018)

Volume 14, Issue 5, Pages (May 2017)

Volume 10, Issue 10, Pages (October 2013)

Volume 13, Issue 4, Pages e222-e237 (April 2016)

Volume 8, Issue 5, Pages (May 2011)

Volume 14, Issue 9, Pages (September 2017)

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Volume 6, Issue 10, Pages (October 2009)

Gaurav A. Upadhyay, MD, Jonathan S. Steinberg, MD Heart Rhythm

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Misconceptions and Facts About Hypertrophic Cardiomyopathy

Volume 9, Issue 4, Pages (April 2012)

Volume 6, Issue 12, Pages (December 2009)

Volume 11, Issue 1, Pages (January 2014)

Volume 13, Issue 7, Pages (July 2016)

Belinda Gray et al. JCHF 2013;1:

Zachary R. McCaw, AM, Ariela R

Volume 11, Issue 2, Pages (February 2014)

Volume 15, Issue 10, Pages e253-e274 (October 2018)

Volume 10, Issue 12, Pages (December 2013)

Volume 9, Issue 1, Pages (January 2012)

Volume 11, Issue 2, Pages (February 2014)

Volume 8, Issue 12, Pages (December 2011)

Mahesh Anantha Narayanan et al. JACEP 2017;3:

Volume 9, Issue 6, Pages (June 2012)

Ethnic and racial disparities in cardiac resynchronization therapy

Volume 15, Issue 1, Pages (January 2018)

Volume 7, Issue 11, (November 2010)

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

Volume 16, Issue 1, Pages e3-e16 (January 2019)

Volume 5, Issue 7, Pages (July 2008)

Volume 9, Issue 1, Pages (January 2012)

Volume 7, Issue 7, Pages (July 2010)

Volume 14, Issue 3, Pages (March 2017)

Volume 14, Issue 12, Pages (December 2017)

Volume 12, Issue 10, Pages (October 2015)

Volume 16, Issue 1, Pages 3-9 (January 2019)

Volume 11, Issue 1, Pages (January 2014)

Volume 9, Issue 8, Pages S14-S17 (August 2012)

Volume 7, Issue 3, Pages (March 2010)

Volume 15, Issue 1, Pages (January 2018)

Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep

Volume 11, Issue 3, Pages (March 2014)

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter- defibrillator Sana M. Al-Khatib, MD, MHS, FHRS, Sasmrita Belbase, NP,

Appropriate use of genetics in a young patient with atrioventricular block and family history of sudden cardiac death Johnni Rudbeck-Resdal, MD, Jens.

Volume 7, Issue 11, Pages (November 2010)

Intangible benefits of volunteering with the Heart Rhythm Society

Impact of generator replacement on the risk of Fidelis lead fracture

Serious case of the hiccups

Volume 7, Issue 8, Pages (August 2010)

Saadia Sherazi et al. JACEP 2015;1:74-80

Cardiac death, target vessel myocardial infarction (MI), target lesion revascularisation (TLR) by Kaplan-Meier method. Cardiac death, target vessel myocardial.

Volume 14, Issue 1, (January 2017)

Transparent sharing of digital health data: A call to action

Volume 16, Issue 6, Pages (June 2019)

Presentation transcript:

Volume 8, Issue 3, Pages 393-400 (March 2011) Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Jonathan P. Piccini, MD, MHS, Sana M. Al-Khatib, MD, MHS, Anne S. Hellkamp, MS, Kevin J. Anstrom, PhD, Jeanne E. Poole, MD, Daniel B. Mark, MD, MPH, Kerry L. Lee, PhD, Gust H. Bardy, MD Heart Rhythm Volume 8, Issue 3, Pages 393-400 (March 2011) DOI: 10.1016/j.hrthm.2010.11.033 Copyright © 2011 Heart Rhythm Society Terms and Conditions

Figure 1 Distribution of time between myocardial infarction and randomization/implantation. Each bar represents 3-month intervals. Heart Rhythm 2011 8, 393-400DOI: (10.1016/j.hrthm.2010.11.033) Copyright © 2011 Heart Rhythm Society Terms and Conditions

Figure 2 Kaplan-Meier event rates in patients treated with an ICD vs. placebo according to time from MI to implantation/randomization (tertiles) for (A) all-cause mortality and (B) sudden cardiac death. Heart Rhythm 2011 8, 393-400DOI: (10.1016/j.hrthm.2010.11.033) Copyright © 2011 Heart Rhythm Society Terms and Conditions

Figure 3 Kaplan-Meier rates of appropriate ICD therapy according to the time from myocardial infarction to implantation/randomization. Heart Rhythm 2011 8, 393-400DOI: (10.1016/j.hrthm.2010.11.033) Copyright © 2011 Heart Rhythm Society Terms and Conditions